Declan Williams

Declan Williams

Auto-generated profile, based on publicly available information

Declan Williams

Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Cell
Verified
Journal Article
Open access
SQSeema Qamar
Seema Qamar
GWGuoZhen Wang
GuoZhen Wang
SRSuzanne J. Randle
Suzanne J. Randle
FRFrancesco Simone Ruggeri
Francesco Simone Ruggeri
JVJuan A. Varela
Juan A. Varela
PGPeter St George-Hyslop
Peter St George-Hyslop
Reversible phase separation underpins the role of FUS in ribonucleoprotein granules and other membrane-free organelles and is, in part, driven by the intrinsically disordered low-complexity (LC) domain of FUS. Here, we report that cooperative cation-π interactions between tyrosines in the LC domain and arginines in structured C-terminal domains also contribute to phase separation. These interactions are modulated by post-translational arginine methylation, wherein arginine hypomethylation strongly promotes phase separation and gelation. Indeed, significant hypomethylation, which occurs in FUS-associated frontotemporal lobar degeneration (FTLD), induces FUS condensation into stable intermolecular β-sheet-rich hydrogels that disrupt RNP granule function and impair new protein synthesis in neuron terminals. We show that transportin acts as a physiological molecular chaperone of FUS in neuron terminals, reducing phase separation and gelation of methylated and hypomethylated FUS and rescuing protein synthesis. These results demonstrate how FUS condensation is physiologically regulated and how perturbations in these mechanisms can lead to disease.

1 March 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AMAmina Makhmoudova
Amina Makhmoudova
DWDeclan Williams
Declan Williams
DBDyanne Brewer
Dyanne Brewer
SMSarah Massey
Sarah Massey
JPJenelle Patterson
Jenelle Patterson
MEMichael J Emes
Michael J Emes
Starch branching enzyme IIb (SBEIIb) plays a crucial role in amylopectin biosynthesis in maize endosperm by defining the structural and functional properties of storage starch and is regulated by protein phosphorylation. Native and recombinant maize SBEIIb were used as substrates for amyloplast protein kinases to identify phosphorylation sites on the protein. A multidisciplinary approach involving bioinformatics, site-directed mutagenesis, and mass spectrometry identified three phosphorylation sites at Ser residues: Ser649, Ser286, and Ser297. Two Ca2+-dependent protein kinase activities were partially purified from amyloplasts, termed K1, responsible for Ser649 and Ser286 phosphorylation, and K2, responsible for Ser649 and Ser297 phosphorylation. The Ser286 and Ser297 phosphorylation sites are conserved in all plant branching enzymes and are located at opposite openings of the 8-stranded parallel β-barrel of the active site, which is involved with substrate binding and catalysis. Molecular dynamics simulation analysis indicates that phospho-Ser297 forms a stable salt bridge with Arg665, part of a conserved Cys-containing domain in plant branching enzymes. Ser649 conservation appears confined to the enzyme in cereals and is not universal, and is presumably associated with functions specific to seed storage. The implications of SBEIIb phosphorylation are considered in terms of the role of the enzyme and the importance of starch biosynthesis for yield and biotechnological application.

2 March 2016 in Oncotarget
Verified
Journal Article
Open access
DBDaniel P. Ball
Daniel P. Ball
ALAndrew M. Lewis
Andrew M. Lewis
DWDeclan Williams
Declan Williams
DRDiana Resetca
Diana Resetca
DWDerek J. Wilson
Derek J. Wilson
PGPatrick Gunning
Patrick Gunning
Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent

26 June 2017 in eLife
Verified
Journal Article
Open access
HWHansen Wang
Hansen Wang
LMLisa D Muiznieks
Lisa D Muiznieks
PGPunam Ghosh
Punam Ghosh
DWDeclan Williams
Declan Williams
MSMichael Solarski
Michael Solarski
Gerold Schmitt-UlmsGerold Schmitt-Ulms
Gerold Schmitt-Ulms
The amyloid β peptide (Aβ) is a key player in the etiology of Alzheimer disease (AD), yet a systematic investigation of its molecular interactions has not been reported. Here we identified by quantitative mass spectrometry proteins in human brain extract that bind to oligomeric Aβ1-42 (oAβ1-42) and/or monomeric Aβ1-42 (mAβ1-42) baits. Remarkably, the cyclic neuroendocrine peptide somatostatin-14 (SST14) was observed to be the most selectively enriched oAβ1-42 binder. The binding interface comprises a central tryptophan within SST14 and the N-terminus of Aβ1-42. The presence of SST14 inhibited Aβ aggregation and masked the ability of several antibodies to detect Aβ. Notably, Aβ1-42, but not Aβ1-40, formed in the presence of SST14 oligomeric assemblies of 50 to 60 kDa that were visualized by gel electrophoresis, nanoparticle tracking analysis and electron microscopy. These findings may be relevant for Aβ-directed diagnostics and may signify a role of SST14 in the etiology of AD.

1 November 2007 in Analytical Biochemistry
Verified
Journal Article
Closed access
MTMonika Tucholska
Monika Tucholska
SSSalvatore Scozzaro
Salvatore Scozzaro
DWDeclan Williams
Declan Williams
SASuzanne Ackloo
Suzanne Ackloo
CLChris Lock
Chris Lock
JMJohn G. Marshall
John G. Marshall

7 November 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XWXinzhu Wang
Xinzhu Wang
DWDeclan Williams
Declan Williams
IMIris Müller
Iris Müller
MLMackenzie Lemieux
Mackenzie Lemieux
RDRamona Dukart
Ramona Dukart
Gerold Schmitt-UlmsGerold Schmitt-Ulms
Gerold Schmitt-Ulms
Protein interactions of Tau are of interest in efforts to decipher pathogenesis in Alzheimer’s disease, a subset of frontotemporal dementias, and other tauopathies. We CRISPR-Cas9 edited two human cell lines to generate broadly adaptable models for neurodegeneration research. We applied the system to inducibly express balanced levels of 3-repeat and 4-repeat wild-type or P301L mutant Tau. Following 12-h induction, quantitative mass spectrometry revealed the Parkinson’s disease-causing protein DJ-1 and non-muscle myosins as Tau interactors whose binding to Tau was profoundly influenced by the presence or absence of the P301L mutation. The presence of wild-type Tau stabilized non-muscle myosins at higher steady-state levels. Strikingly, in human differentiated co-cultures of neuronal and glial cells, the preferential interaction of non-muscle myosins to wild-type Tau depended on myosin ATPase activity. Consistently, transgenic P301L Tau mice exhibited reduced phosphorylation of regulatory myosin light chains known to activate this ATPase. The direct link of Tau to non-muscle myosins corroborates independently proposed roles of Tau in maintaining dendritic spines and mitochondrial fission biology, two subcellular niches affected early in tauopathies.